Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04219891 · ClinicalTrials.gov registry record · NA
WaveLight® EX500 Excimer Laser System for the Correction of Myopia Using InnovEyes™ in Conjunction With InnovEyes™ Sightmap
A NA study, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 272
- Enrollment target
NCT04219891 is a NA study that has completed, run by Alcon Research. The registered enrollment target is 272 participants.
The verdict
NCT04219891, a NA study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 272 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and effectiveness of the WaveLight EX500 excimer laser system for the correction of myopia with and without astigmatism using InnovEyes in conjunction with InnovEyes sightmap.
Interventions
- PROCEDURE LASIK
- DEVICE WaveLight EX500 excimer laser system with InnovEyes sightmap
- DEVICE InnovEyes sightmap
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 272 participants |
| Start Date | 2020-03-09 |
| Est. Completion | 2022-11-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04219891
The ClinicalTrials.gov registry entry for NCT04219891 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 272 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which LASIK is the first listed.
NCT04219891 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04219891 about?
NCT04219891 is a clinical study titled "WaveLight® EX500 Excimer Laser System for the Correction of Myopia Using InnovEyes™ in Conjunction With InnovEyes™ Sightmap". The purpose of this study is to evaluate the safety and effectiveness of the WaveLight EX500 excimer laser system for the correction of myopia with and without astigmatism using InnovEyes in conjunction with InnovEyes sightmap.
What is the current status of trial NCT04219891?
This trial is currently completed. It is a NA study. The enrollment target is 272 participants. The study started on 2020-03-09. Estimated completion is 2022-11-09.
What interventions are being tested in trial NCT04219891?
The interventions under investigation include: LASIK (PROCEDURE), WaveLight EX500 excimer laser system with InnovEyes sightmap (DEVICE), InnovEyes sightmap (DEVICE).
Who is sponsoring clinical trial NCT04219891?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.